🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT04038424
Starting soon Not applicable

The Effect of Art Therapy on Patients With Stroke

NCT04038424 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-12-30
Last updated
2025-08-14

Condition(s) studied

Ischemic Stroke and Hemorrhagic Stroke

Investigational drug(s) / intervention(s)

Art therapy

Art therapy: Art therapy including coloring, painting and listening to music

Study summary

Stroke can affect the physical, emotional and social aspects of the patient and their family members. It is the main cause of complex disability, with a high number of people living with its effects. Stroke can result in impairments in motor function, language, cognition, sensory processing, cognition, and emotional disturbances, which can affect the performance of functional activities and mental health status. Getting patients involved in art therapy (AT) class has shown to alleviate stress and promote a sense of wellbeing, which can aid their recovery and rehabilitation. The benefits of art therapy for people living with different health conditions worldwide have been reported, however, its effect on Egyptian patients with stroke has been neglected.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * able to sit upright, supported or unsupported, * oriented to time and place by using the adapted Arabic Memory Screening Test, * able to perform at least two of the following skills: drinking from a cup, eating with a spoon and taking money from a purse by the affected arm, and * will stay in the stroke unit to at least 4 days (for receiving three sessions out of all sessions) before discharge, Exclusion Criteria: * diagnosis of transient ischemic attack or brain stem stroke; * unconscious; * unable to provide informed consent; * hemodynamical unstable medical conditions, including fever; * serious infectious diseases, for example, viral hepatitis or HIV; and/or * severe dementia or uncontrolled psychiatric problems.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Unit of stroke and cerebral vascular disease treatment Cairo Egypt

More Cairo University trials in Egypt

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04038424 on ClinicalTrials.gov ↗ ← All trials in Egypt